
Rallybio Corporation Investor Relations Material
Latest events

Status Update
Rallybio Corporation

Corporate Presentation
11 Jun, 2025

Q1 2025
8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rallybio Corporation
Access all reports
Rallybio Corporation is a biotechnology company focused on developing therapies for rare and severe diseases. The company specializes in antibody and protein-based treatments targeting immune and hematological disorders. Its research and development efforts aim to address conditions with high unmet medical needs through clinical trials and collaborations with scientific partners. The company is headquartered in New Haven, Connecticut, and its shares are listed on the NASDAQ.
Key slides for Rallybio Corporation


Status Update
Rallybio Corporation


Corporate Presentation
Rallybio Corporation
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
RLYB
Country
🇺🇸 United States